Sort
23,748 grants matching “melanoma”
Gamma Delta T Cells--Immunotherapy for Melanoma
$238,569University Of Alabama At Birmingham · R01 · FY2003 · CA
Cancer Genetics
$238,509Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2013 · CA
The molecular analysis of Gab3 in NK cell function
$238,500Kasper Hoebe · Cincinnati Childrens Hosp Med Ctr · R21 · FY2018 · AI
Treating Melanoma with a Molecularly Engineered, Long Circulating Immunotoxin
$238,500Ashutosh Chilkoti · Duke University · R21 · FY2015 · EB
Targeting Malignant Stem Cells in CLL
$238,479Margaret Goodell · Baylor College Of Medicine · P50 · FY2011 · CA
Cancer Center Support Grant
$238,405Craig B Thompson · Sloan-Kettering Inst Can Research · P30 · FY2013 · CA
Multimodal multifocal confocal Raman and phase microscopy with enhanced resolution
$238,328Peter T. So · Massachusetts Institute Of Technology · P41 · FY2017 · EB
The Role of JAM-C in Adhesive Interactions of Immune Cells
$238,211Triantafyllos Chavakis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Contribution of myeloid cells to the anti-tumor adaptive immune response after radiation in a pediatric brain tumor
$238,140Mai T Dang · Washington University · K08 · FY2023 · CA
Contribution of myeloid cells to the anti-tumor adaptive immune response after radiation in a pediatric brain tumor
$238,140Mai T Dang · Washington University · K08 · FY2024 · CA
Dendritic cell based therapies for murine tumors
$238,090University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Type-1 Antigen Presenting Cells in CNS Tumors - Key to Efficient Anti-Tumor T-Cel
$238,036Hideho Okada · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA
Oral adjuvant enhances induction of anti-tumor response
$238,023William Guy Bradley · Tampa Bay Research Institute · R21 · FY2006 · AT
ROLE OF KAISO IN METASTASIS
$238,022Vanderbilt University · R01 · FY2002 · CA
Targeting RAS in Pediatric Cancer
$237,960Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
$237,941Rona Yaeger · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma
$237,930Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2017 · CA
CORE--NUDE/SCID MOUSE FACILITY
$237,900University Of California Los Angeles · P30 · FY2000 · CA
Developing techniques to generate the first transgenic opossums
$237,900Karen E Sears · University Of Illinois At Urbana-Champaign · R21 · FY2016 · OD
ROLE OF KAISO IN METASTASIS
$237,825Vanderbilt University · R01 · FY2003 · CA
Tumor therapy with antiangiogenic beta-2-glycoprotein 1
$237,825University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
ROLE OF KAISO IN METASTASIS
$237,825Vanderbilt University · R01 · FY2004 · CA
Tumor therapy with antiangiogenic beta-2-glycoprotein 1
$237,825University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
GENETIC CONTROL OF CELL FATE DIVERSITY IN DROSOPHILA
$237,793Duke University · R01 · FY2001 · GM
Targeting ROS enzymes in immunosuppressive myeloid cells to enhance immunotherapy
$237,783Tracy W Liu · West Virginia University · P20 · FY2023 · GM